Inhalation development and manufacturing for early and late-stage clinical supply.

SMoldons Pharmaceuticals UK Inhalation Solutions™ offers comprehensive contract development and manufacturing solutions for early and late-phase clinical supply from our stand-alone pilot plant as part of our integrated inhalation offering.

Our pilot plant comprises seven independent suites totalling approximately 900m2 of manufacturing space to enable GMP supply of investigational medicinal products (IMPs), with a focus on nasal sprays and inhalers.